Strengthening the Flow of the Biotech Sector’s M&A Pipeline

Originally published in Genetic Engineering News on October 10, 2023. Reprinted with permission. The biotechnology sector has long been characterized by its constant innovation, rapid technological progress, and unyielding commitment to combating diseases. These attributes are more than passingly related to the sector’s propensity for collaborative ventures and mergers and acquisitions (M&A). Prospects for entering into agreements and […]